Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Nymox Pharmaceutical Corp. | 0 | 2 | 0 | 0 | €0.23 | - | - |
| Cyclacel Pharmaceuticals Inc. | 1 | 12 | 0 | 0 | €0.22 | €19.12 | 8591.136% |
| CytoTools AG | 0 | 1 | 0 | 0 | €0.43 | - | - |
| Karyopharm Therapeutics Inc. | 7 | 2 | 0 | 0 | €1.03 | €3.65 | 255.694% |
| Roche Holding AG ADR | 2 | 1 | 0 | 0 | €27.28 | €38.00 | 39.288% |
| Organovo Holdings Inc. | 0 | 5 | 0 | 0 | €0.89 | - | - |
| Formycon AG | 3 | 1 | 0 | 0 | €41.20 | €100.00 | 142.718% |
| Elanco Animal Health Inc. | 6 | 3 | 0 | 0 | €12.33 | €15.50 | 25.783% |
| NanoCarrier Co Ltd | 0 | 1 | 0 | 0 | €0.77 | - | - |
| Neptune Wellness Solutions Inc | 0 | 13 | 0 | 0 | €0.14 | - | - |
| Grifols S.A. ADR | 0 | 1 | 0 | 0 | €5.75 | - | - |
| Coherus Bioscien. | 2 | 2 | 0 | 0 | €2.02 | €3.00 | 48.588% |
| Shin Nippon Biomedical Laboratories Ltd. | 0 | 1 | 0 | 0 | €8.95 | - | - |
| Chimerix Inc. | 4 | 1 | 0 | 0 | €0.84 | €5.51 | 557.282% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 2 | 0 | €35.60 | €50.00 | 40.449% |
| BioLine RX Ltd ADR | 0 | 2 | 0 | 0 | €0.62 | - | - |
| Bluebird Bio Inc. | 4 | 6 | 0 | 0 | €0.84 | €8.82 | 950.715% |
| Corvus Pharmaceuticals Inc | 4 | 1 | 0 | 1 | €1.42 | €5.10 | 259.866% |
| Applied Therapeutics Inc | 1 | 1 | 0 | 1 | €4.22 | €4.00 | -5.213% |
| Sage Therapeutics Inc. | 5 | 3 | 1 | 1 | €12.22 | €26.71 | 118.705% |
| Tonix Pharmaceuticals Holding Corp. | 2 | 15 | 0 | 1 | €2.82 | €5.03 | 78.387% |
| Sangamo Therapeutics Inc. | 11 | 13 | 0 | 1 | €0.49 | €2.79 | 474.168% |
| Protalix Biotherapeutics Inc. | 1 | 1 | 0 | 1 | €1.07 | €2.00 | 86.480% |
| Minerva Neurosciences Inc. | 1 | 5 | 0 | 1 | €2.26 | €7.00 | 209.735% |
| Acadia Pharmaceuticals | 23 | 1 | 3 | 1 | €15.62 | €32.59 | 108.678% |